Simethicone helps break up gas bubbles in your stomach and intestines to relieve bloating, pressure, and discomfort from excess gas.[1] Gas-X is currently being investigated across 4 indications[3], with its most advanced program in Phase 3.[1]
Gas-X is one of 107 small molecule programs targeting Dyspepsia. It is currently in Phase 3.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
268 competitors in Colorectal Cancer
Stivarga
Camptosar
Keytruda
Wellcovorin
Wellcovorin
Platinol
Acetylsalicylic Acid
Gas-X
Huaier Granule
BL-M07D1
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources
Details